Podcast: Parsing Science: The unpublished stories behind the world’s most compelling science, as told by the researchers themselves. (LS 28 · TOP 10% what is this?)
Episode: Silencing an ALS Gene – Tim Miller
Pub date: 2020-11-10

Notes from The Listener:

Interview series that seeks to uncover the unpublished, often personal, stories from the researchers behind scientific publications. This one stood out both because of the potential significance of the work and the quiet humility of the man doing it. The guest works on targeted gene therapies for ALS (also known as Lou Gehrig's disease), a progressive and degenerative condition of the nervous system. The format of this show, which balances conversation with narration, strikes a good balance between detail and approachability

How could a gene that causes one type of ALS be switched off? In episode 87, Tim Miller from the Washington University in St. Louis discusses his research into therapies that target the single strands of DNA or RNA which cause many cases of amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's disease.

The podcast and artwork embedded on this page are from Parsing Science: The unpublished stories behind the world’s most compelling science, as told by the researchers themselves., which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.